Axogen (AXGN) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Axogen (AXGN) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 13.80% |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 73.85% |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | 12.92% |
| 10 | Axogen | 2.43 Bn | 2.32 Bn | 50.67 Mn | -1,613.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,175.00% |
| Mar 31, 2026 | 24.21% |
| Dec 31, 2025 | -7,905.47% |
| Sep 30, 2025 | 120.54% |
| Jun 30, 2025 | 96.65% |
| Mar 31, 2025 | 44.81% |
| Dec 31, 2024 | 97.28% |
| Sep 30, 2024 | 63.91% |
| Jun 30, 2024 | 71.15% |
| Mar 31, 2024 | 20.80% |
| Dec 31, 2023 | -3.39% |
| Sep 30, 2023 | 10.44% |
| Jun 30, 2023 | 9.06% |
| Mar 31, 2023 | 33.69% |
| Dec 31, 2022 | 13.70% |
| Sep 30, 2022 | 24.99% |
| Jun 30, 2022 | -14.16% |
| Mar 31, 2022 | -89.34% |
| Dec 31, 2021 | 7.28% |
| Sep 30, 2021 | 33.80% |